Citations

Clear

8 citation(s) found for "Shen, Huahao".

In vitroassessment of chemokine receptor-ligand interactions mediating mouse eosinophil migration
Borchers, Michael T. , Ansay, Tracy, DeSalle, Rob , Daugherty, Bruce L. , Shen, Huahao , Lee, Nancy A., Lee, James J. , Metzger, Michael J.

Mayo Clinic

Journal of Leukocyte Biology | September 28, 2022 | Volume: 71 | Issue: 6 | Pages: 1033-1041

10.1189/jlb.71.6.1033 Get It

AbstractEosinophil migration from circulation is controlled, in part, by chemokines through a family of G-protein-coupled chemokine receptors (CCR). Studies of human eosinophils have demonstrated that signaling through CCR3 receptors is a prominent pathway leading to chemotaxis, although several other receptor-ligand interactions also appear to mediate eosinophil recruitment. The availability of genetically unique strains of mice permits a reductionist approach to assess the signaling pathways in experimental models of human disease. However, despite similarities in these pathways between mice and humans, significant species differences exist, complicating the translation of results from animal models to humans. Purified mouse eosinophils were used in this study to investigate the chemokine receptor expression and the activities of 18 chemokines. Mouse eosinophils isolated from IL-5 transgenic mice expressed transcripts encoding the chemokine receptors CCR1, CCR2, CCR3, CCR5, CCR8, CXCR2, and CXCR4, but not CCR4. Mouse eosinophils also migrated in response to human and mouse eotaxin-1 and -2, but not human eotaxin-3. In addition, the induced migration of mouse eosinophils by TARC, MIP-1β, and KC suggests that unidentified receptor-ligand interactions contribute to eosinophil recruitment. It is interesting that the potent chemoattractant of human eosinophils, RANTES, was unable to mediate mouse eosinophil migration. Furthermore, despite the ability of MIP-1α to bind receptors on purified mouse eosinophils, it was only able to induce significant eosinophil migration in a mixed splenocyte population and was unable to induce migration of highly purified eosinophils. Collectively, these observations reveal physiologically relevant distinctions in mechanisms mediating human and mouse eosinophil migration that potentially reflect evolutionary disparities between these species.
Ectopic expression of IL-5 identifies an additional CD4+T cell mechanism of airway eosinophil recruitment
Crosby, Jeffrey R., Shen, Huahao , Borchers, Michael T. , Justice, J. Paul, Ansay, Tracy, Lee, J. J., Lee, N. A., Lee, J. J.

Mayo Clinic

American Journal of Physiology-Lung Cellular and Molecular Physiology | December 23, 2017 | Volume: 282 | Issue: 1 | Pages: L99-L108

10.1152/ajplung.2002.282.1.l99 | PMID 11741821 Get It

CD4+T cells have a critical role in the development of allergic pulmonary inflammation, including the recruitment of eosinophils to the airway lumen and interstitium. The expression of interleukin (IL)-5 by CD4+cells has, in particular, often been lionized as the central link between allergic inflammation and the concomitant expansion or recruitment of eosinophils. The mechanism(s) by which CD4+T cells mediates eosinophil recruitment was assessed with gene knockout mice deficient for T cells or T cell subtypes and a unique IL-5 transgenic mouse (line NJ.1726) that constitutively overexpresses this cytokine in the lung epithelium. Pulmonary IL-5 expression is significantly attenuated in T cell- and CD4+but not CD8+cell-deficient animals, suggesting an obvious explanation for the lack of eosinophils in the lungs of T cell-deficient and CD4(−/−) mice. However, although the constitutive expression of IL-5 in the lung epithelium of NJ.1726 mice elicited an eosinophilia in the airway lumen of both naive and ovalbumin-treated mice, in the absence of CD4+cells, allergen-mediated eosinophil recruitment to the bronchoalveolar lavage fluid was abolished. Moreover, intranasal instillation of the potent eosinophil-specific chemokine eotaxin-2 was incapable of eliciting eosinophil recruitment in naive and ovalbumin-treated NJ.1726 CD4(−/−) mice, suggesting that eosinophil trafficking during allergic inflammatory responses is a consequence of a CD4+cell-mediated event(s) in addition to IL-5 expression and the establishment of a pulmonary chemokine gradient.
Lung Pathologies in a Chronic Inflammation Mouse Model Are Independent of Eosinophil Degranulation
Jacobsen, Elizabeth A. , Ochkur, Sergei I. , Doyle, Alfred D. , LeSuer, William E., Li, Wen , Protheroe, Cheryl, Colbert, Dana, Zellner, Katie R. , Shen, Huahao , Irvin, Charles G. , Lee, James J. , Lee, Nancy A., Protheroe, Cheryl A, Jacobsen, Elizabeth A

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | March 6, 2017 | Volume: 195 | Issue: 10 | Pages: 1321-1332

10.1164/rccm.201606-1129oc | PMID 27922744 Get It

Abstract Rationale The release of eosinophil granule proteins in the lungs of patients with asthma has been dogmatically linked with lung remodeling and airway hyperresponsiveness. However, the demonstrated inability of established mouse models to display the eosinophil degranulation occurring in human subjects has prevented a definitive in vivo test of this hypothesis. Objectives To demonstrate in vivo causative links between induced pulmonary histopathologies/lung dysfunction and eosinophil degranulation. Methods A transgenic mouse model of chronic T-helper cell type 2–driven inflammation overexpressing IL-5 from T cells and human eotaxin 2 in the lung (I5/hE2) was used to test the hypothesis that chronic histopathologies and the development of airway hyperresponsiveness occur as a consequence of extensive eosinophil degranulation in the lung parenchyma. Measurement and Main Results Studies targeting specific inflammatory pathways in I5/hE2 mice surprisingly showed that eosinophil-dependent immunoregulative events and not the release of individual secondary granule proteins are the central contributors to T-helper cell type 2–induced pulmonary remodeling and lung dysfunction. Specifically, our studies highlighted a significant role for eosinophil-dependent IL-13 expression. In contrast, extensive degranulation leading to the release of major basic protein-1 or eosinophil peroxidase was not causatively linked to many of the induced pulmonary histopathologies. However, these studies did define a previously unappreciated link between the release of eosinophil peroxidase (but not major basic protein-1) and observed levels of induced airway mucin. Conclusions These data suggest that improvements observed in patients with asthma responding to therapeutic strategies ablating eosinophils may occur as a consequence of targeting immunoregulatory mechanisms and not by simply eliminating the destructive activities of these purportedly end-stage effector cells.
Ablation of eosinophils leads to a reduction of allergen-induced pulmonary pathology
Justice, J. Paul, Borchers, Michael T. , Crosby, Jeffrey R., Hines, Edith M., Shen, Huahao , Ochkur, Sergei I. , McGarry, Michael P. , Lee, Nancy A., Lee, James J.

Mayo Clinic

American Journal of Physiology-Lung Cellular and Molecular Physiology | March 3, 2015 | Volume: 284 | Issue: 1 | Pages: L169-L178

10.1152/ajplung.00260.2002 | PMID 12388345 Get It

A strategy to deplete eosinophils from the lungs of ovalbumin (OVA)-sensitized/challenged mice was developed using antibody-mediated depletion. Concurrent administration [viz. the peritoneal cavity (systemic) and as an aerosol to the lung (local)] of a rat anti-mouse CCR3 monoclonal antibody resulted in the abolition of eosinophils from the lung such that the airway lumen was essentially devoid of eosinophils. Moreover, perivascular/peribronchial eosinophil numbers were reduced to levels indistinguishable from saline-challenged animals. This antibody-mediated depletion was not accompanied by effects on any other leukocyte population, including, but not limited to, T cells and mast cells/basophils. In addition, no effects were observed on other underlying allergic inflammatory responses in OVA-treated mice, including OVA-specific immunoglobulin production as well as T cell-dependent elaboration of Th2 cytokines. The ablation of virtually all pulmonary eosinophils in OVA-treated mice (i.e., without concurrent effects on T cell activities) resulted in a significant decrease in mucus accumulation and abolished allergen-induced airway hyperresponsiveness. These data demonstrate a direct causative relationship between allergen-mediated pulmonary pathologies and eosinophils.
Exogenous Interleukin-17A Inhibits Eosinophil Differentiation and Alleviates Allergic Airway Inflammation
Tian, Baoping, Wen, Hua , Xia, Lixia, Jin, Yan, Lan, Fen , Lee, James J. , Lee, Nancy A., Ying, Songmin , Chen, Zhihua , Shen, Huahao , Li, Wen

Mayo Clinic

American Journal of Respiratory Cell and Molecular Biology | September 2, 2014 | Volume: 52 | Issue: 4 | Pages: 459-470

10.1165/rcmb.2014-0097oc | PMID 25180833 Get It

Abstract IL-17 is known to play important roles in immune and inflammatory disease, such as in asthma, but its functions in allergic airway inflammation are still controversial, and the molecular mechanisms mediating these functions remain unclear. Increased production of eosinophils in bone marrow and their emergence in the airway have been linked to the onset and progression of allergic asthma. In this study, we investigated the effects of exogenous IL-17 on allergic airway inflammation and explored the underlying molecular mechanisms through eosinophil generation. Exogenous IL-17 significantly attenuated the features of allergic inflammation induced by ovalbumin in mice. It inhibited eosinophil differentiation both in vivo and in vitro, accompanied by down-regulated expression of CC chemokine receptor 3, GATA binding protein 1 (GATA-1), and GATA binding protein 2 (GATA-2), as well as reduced formation of common myeloid progenitors and eosinophil progenitors, but without influencing eosinophil apoptosis. IL-17 also significantly decreased the number of eosinophils in IL-5–transgenic mice, although it notably increased the levels of IL-3, IL-5, and granulocyte/macrophage colony–stimulating factor. In addition, IL-17 had little effect on secretion of the inflammatory cytokines by eosinophils. Neutralization of endogenous IL-17 significantly augmented eosinophil recruitment in the airways. Together, these findings suggest that exogenous IL-17 protects against allergic airway inflammation, most likely through inhibition of the eosinophil differentiation in bone marrow.
A Causative Relationship Exists Between Eosinophils and the Development of Allergic Pulmonary Pathologies in the Mouse
Shen, Hua-Hao, Ochkur, Sergei I. , McGarry, Michael P. , Crosby, Jeffrey R., Hines, Edie M., Borchers, Michael T. , Wang, Huiying , Biechelle, Travis L., O'Neill, K.R. , Ansay, Tracy, Colbert, Dana, Cormier, Stephania A. , Justice, J. Paul, Lee, Nancy A., Lee, James J. , Shen, HuaHao H

Mayo Clinic

The Journal of Immunology | April 20, 2014 | Volume: 170 | Issue: 6 | Pages: 3296-3305

10.4049/jimmunol.170.6.3296 | PMID 12626589 Get It

Abstract Asthma and mouse models of allergic respiratory inflammation are invariably associated with a pulmonary eosinophilia; however, this association has remained correlative. In this report, a causative relationship between eosinophils and allergen-provoked pathologies was established using eosinophil adoptive transfer. Eosinophils were transferred directly into the lungs of either naive or OVA-treated IL-5−/− mice. This strategy resulted in a pulmonary eosinophilia equivalent to that observed in OVA-treated wild-type animals. A concomitant consequence of this eosinophil transfer was an increase in Th2 bronchoalveolar lavage cytokine levels and the restoration of intracellular epithelial mucus in OVA-treated IL-5−/− mice equivalent to OVA-treated wild-type levels. Moreover, the transfer also resulted in the development of airway hyperresponsiveness. These pulmonary changes did not occur when eosinophils were transferred into naive IL-5−/− mice, eliminating nonspecific consequences of the eosinophil transfer as a possible explanation. Significantly, administration of OVA-treated IL-5−/− mice with GK1.5 (anti-CD4) Abs abolished the increases in mucus accumulation and airway hyperresponsiveness following adoptive transfer of eosinophils. Thus, CD4+ T cell-mediated inflammatory signals as well as signals derived from eosinophils are each necessary, yet alone insufficient, for the development of allergic pulmonary pathology. These data support an expanded view of T cell and eosinophil activities and suggest that eosinophil effector functions impinge directly on lung function.
Coexpression of IL-5 and Eotaxin-2 in Mice Creates an Eosinophil-Dependent Model of Respiratory Inflammation with Characteristics of Severe Asthma
Ochkur, Sergei I. , Jacobsen, Elizabeth A. , Protheroe, Cheryl, Biechele, Travis L., Pero, Ralph, McGarry, Michael P. , O'Neill, K.R. , Colbert, Dana, Colby, Thomas V. , Shen, Huahao , Irvin, Charles, Lee, James J. , Lee, Nancy A., Wang, Huiying , Blackburn, Michael R. , Jacobsen, Elizabeth A

Mayo Clinic

The Journal of Immunology | April 18, 2014 | Volume: 178 | Issue: 12 | Pages: 7879-7889

10.4049/jimmunol.178.12.7879 | PMID 17548626 Get It

Abstract Mouse models of allergen provocation and/or transgenic gene expression have provided significant insights regarding the cellular, molecular, and immune responses linked to the pathologies occurring as a result of allergic respiratory inflammation. Nonetheless, the inability to replicate the eosinophil activities occurring in patients with asthma has limited their usefulness to understand the larger role(s) of eosinophils in disease pathologies. These limitations have led us to develop an allergen-naive double transgenic mouse model that expresses IL-5 systemically from mature T cells and eotaxin-2 locally from lung epithelial cells. We show that these mice develop several pulmonary pathologies representative of severe asthma, including structural remodeling events such as epithelial desquamation and mucus hypersecretion leading to airway obstruction, subepithelial fibrosis, airway smooth muscle hyperplasia, and pathophysiological changes exemplified by exacerbated methacholine-induced airway hyperresponsiveness. More importantly, and similar to human patients, the pulmonary pathologies observed are accompanied by extensive eosinophil degranulation. Genetic ablation of all eosinophils from this double transgenic model abolished the induced pulmonary pathologies, demonstrating that these pathologies are a consequence of one or more eosinophil effector functions.
Gα i2 -mediated signaling events in the endothelium are involved in controlling leukocyte extravasation
Pero, Ralph, Borchers, Michael T. , Spicher, Karsten, Ochkur, Sergei I. , Sikora, Lyudmila, Sriramarao, P. , O'Neill, K.R. , Shen, Huahao , McGarry, Michael P. , Lee, Nancy A., Simon, Melvin I., Birnbaumer, Lutz , Lee, James J. , Abdala‐Valencia, Hiam , Cook‐Mills, Joan M.

Mayo Clinic

Proceedings of the National Academy of Sciences | March 7, 2007 | Volume: 104 | Issue: 11 | Pages: 4371-4376

10.1073/pnas.0700185104 | PMID 17360531 Get It

The trafficking of leukocytes from the blood to sites of inflammation is the cumulative result of receptor-ligand-mediated signaling events associated with the leukocytes themselves as well as with the underlying vascular endothelium. Our data show that Gα i signaling pathways in the vascular endothelium regulate a critical step required for leukocyte diapedesis. In vivo studies using knockout mice demonstrated that a signaling event in a non-lymphohematopoietic compartment of the lung prevented the recruitment of proinflammatory leukocytes. Intravital microscopy showed that blockade was at the capillary endothelial surface and ex vivo studies of leukocyte trafficking demonstrated that a Gα i -signaling event in endothelial cells was required for transmigration. Collectively, these data suggest that specific Gα i2 -mediated signaling between endothelial cells and leukocytes is required for the extravasation of leukocytes and for tissue-specific accumulation.